Comparison | CHI | Start (bp) | End (bp) | N SNPs | W Fst | Genes |
---|---|---|---|---|---|---|
Metapopulation | 6 | 13,500,001 | 14,000,000 | 6 | 0.158 | ALPK1*, TIFA*, AP1AR*, C6H4orf32* |
6 | 13,750,001 | 14,250,000 | 6 | 0.297 | – | |
6 | 14,000,001 | 14,500,000 | 9 | 0.227 | – | |
17 | 1,000,001 | 1,500,000 | 8 | 0.145 | PISD, SFI1, EIF4ENIF1, DRG1, PATZ1, PIK3IP1, LIMK2, CRKL, RNF185, PLA2G3, INPP5J, SMTN, MORC2 | |
19 | 33,000,001 | 33,500,000 | 11 | 0.160 | PIGL, NCOR1, TTC19, ZSWIM7, ADORA2B, AKAP10, ULK2 | |
PAL_MAJ | 4 | 110,750,001 | 111,250,000 | 12 | 0.417 | PEX1, TRNAG-CCC, GATAD1, ANKIB1, KRIT1, LRRD1, AKAP9, TRNAC-GCA |
6 | 37,750,001 | 38,250,000 | 7 | 0.540 | FAM184B*, DCAF16*, NCAPG*, LCORL*, TRNAC-GCA | |
6 | 111,500,001 | 112,000,000 | 7 | 0.420 | PROM1, TAPT1, LDB2 | |
12 | 57,750,001 | 58,250,000 | 9 | 0.456 | FRY, ZAR1L, BRCA2, N4BP2L1, N4BP2L2, PDS5B | |
12 | 5,800,0001 | 5,850,0000 | 8 | 0.434 | – | |
MAJ_TIN | 2 | 99,000,001 | 99,500,000 | 8 | 0.198 | TANC1, WDSUB1, BAZ2B, TRNAC-ACA |
6 | 13,750,001 | 14,250,000 | 6 | 0.251 | – | |
6 | 14,000,001 | 14,500,000 | 9 | 0.197 | – | |
6 | 35,000,001 | 35,500,000 | 9 | 0.247 | CCSER1, MMRN1, SNCA | |
19 | 19,000,001 | 19,500,000 | 6 | 0.210 | NOS2, LYRM9, NLK | |
PAL_TIS | 6 | 13,750,001 | 14,250,000 | 6 | 0.407 | – |
6 | 17,750,001 | 18,250,000 | 7 | 0.378 | PAPSS1* | |
6 | 111,500,001 | 112,000,000 | 7 | 0.404 | PROM1, TAPT1, LDB2 | |
9 | 20,250,001 | 20,750,000 | 6 | 0.373 | NUS1, GOPC, DCBLD1, ROS1, VGLL2 | |
21 | 62,250,001 | 62,750,000 | 12 | 0.367 | – | |
TIN_TIS | 6 | 13,750,001 | 14,250,000 | 6 | 0.248 | – |
6 | 14,000,001 | 14,500,000 | 9 | 0.211 | / | |
6 | 37,750,001 | 38,250,000 | 7 | 0.222 | FAM184B*, DCAF16*, NCAPG*, LCORL*, TRNAC-GCA | |
11 | 38,000,001 | 38,500,000 | 6 | 0.242 | EFEMP1, MIR217, MIR216B, CCDC85A | |
12 | 60,500,001 | 61,000,000 | 5 | 0.223 | NBEA, MAB21L1, TRNAE-UUC |